Skip to main content
MedPathMedPath Home
Clinical Trials/IRCT20230910059395N1
IRCT20230910059395N1
Recruiting
Phase 3

Comparing the effect of basal insulin with modified-release gliclazide on glycemic control in type 2 diabetic patients with HbA1C above 10%

Oroumia University of Medical Sciences0 sites90 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Oroumia University of Medical Sciences
Enrollment
90
Status
Recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Oroumia University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • •Type 2 diabetes patients with HbA1C above 10%
  • •Age over 30 years

Exclusion Criteria

  • •Patients with kidney and liver failure
  • •Heart failure
  • •Previous receipt of gliclazide and insulin
  • •Gastric problems
  • •Consumption of sulfonylureas
  • •Urine ketone positivity while having symptoms of polyuria
  • •Diabetic ketoacidosis

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
Comparison of two different techniques(insulin bolus vs glucose insulin infusion) to control blood glucose levels during surgery
CTRI/2017/12/011037Dr Arun P
Completed
Not Applicable
PH Insulin efficacy in diabetes management
IRCT2013040912938N2Ronak Daru Company of pharmacy196
Completed
Phase 2
Comparison of the effect of crystalline insulin and topical oxygen on pressure ulcer healingbedsore.Other disorders of skin and subcutaneous tissue in diseases classified elsewhere
IRCT20210508051228N2Shahre-kord University of Medical Sciences60
Completed
Not Applicable
Evaluating the effect of a new supplement on recovery after open heart surgery
IRCT201312102480N3Shiraz University of Medical Sciences92
Active, not recruiting
Not Applicable
A Randomized Trial Comparing either Basal Insulin/Glargine, Exenatide and Metformin Therapy (BET) or Basal Insulin/Glargine, Bolus Insulin Lispro and Metformin Therapy (BBT) in Subjects with Type 2 Diabetes who were previously treated by basal insulin Glargine with either metformin or metformin and sulfonylurea - NDType 2 DiabetesMedDRA version: 9.1Level: LLTClassification code 10012594
EUCTR2009-009500-39-ITELI LILLY760